Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mary Larsen Bouxsein, Ph.D.

Co-Author

This page shows the publications co-authored by Mary Bouxsein and Joy Tsai.
Connection Strength

0.983
  1. Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study. J Bone Miner Res. 2021 01; 36(1):41-51.
    View in: PubMed
    Score: 0.224
  2. Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT Study. J Bone Miner Res. 2019 May; 34(5):976.
    View in: PubMed
    Score: 0.203
  3. Bone Material Strength Index as Measured by Impact Microindentation in Postmenopausal Women With Distal Radius and Hip Fractures. J Bone Miner Res. 2018 04; 33(4):621-626.
    View in: PubMed
    Score: 0.184
  4. Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study. J Bone Miner Res. 2017 Oct; 32(10):2001-2009.
    View in: PubMed
    Score: 0.180
  5. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study. J Bone Miner Res. 2015 Jan; 30(1):39-45.
    View in: PubMed
    Score: 0.151
  6. Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics. Bone. 2016 08; 89:73-74.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.